DNA/NN
Pooling/NN
as/IN
a/DT
Tool/NN
for/IN
Case-Control/NN
Association/NN
Studies/NNS
of/IN
Complex/NN
Traits/NNS
./.
====================
Case-control/NN
studies/NNS
are/VBP
widely/RB
used/VBN
for/IN
disease/NN
gene/NN
====================
mapping/VBG
using/VBG
individual/JJ
genotyping/VBG
data/NNS
./.
====================
However/RB
,/,
analyses/NNS
of/IN
large/JJ
samples/NNS
are/VBP
often/RB
impractical/JJ
due/JJ
to/TO
the/DT
expense/NN
of/IN
individual/JJ
genotyping/VBG
./.
====================
The/DT
use/NN
of/IN
DNA/NN
pooling/NN
can/MD
significantly/RB
reduce/VB
the/DT
number/NN
of/IN
genotyping/VBG
reactions/NNS
required/VBN
;/:
hence/RB
reducing/VBG
the/DT
cost/JJ
of/IN
large-scale/JJ
case-control/JJ
association/NN
studies/NNS
./.
====================
Here/RB
,/,
we/PRP
discuss/VBP
the/DT
design/NN
and/CC
analysis/NN
of/IN
DNA/NN
pooling/NN
genetic/JJ
association/NN
studies/NNS
./.
====================
Two/CD
types/NNS
of/IN
statistical/JJ
methods/NNS
have/VBP
been/VBN
widely/RB
used/VBN
to/TO
attempt/VB
to/TO
identify/VB
genetic/JJ
determinants/NNS
of/IN
diseases/NNS
./.
====================
One/CD
is/VBZ
a/DT
linkage/NN
analysis/NN
and/CC
the/DT
other/JJ
is/VBZ
an/DT
association/NN
study/NN
./.
====================
Linkage/JJ
analysis/NN
methods/NNS
attempt/NN
to/TO
find/VB
out/IN
the/DT
rough/JJ
location/NN
of/IN
the/DT
disease/NN
gene/NN
relative/JJ
to/TO
another/DT
DNA/NN
sequence/NN
called/VBN
a/DT
genetic/JJ
marker/NN
,/,
which/WDT
has/VBZ
its/PRP$
position/NN
on/IN
the/DT
chromosome/NN
already/RB
known/VBN
./.
====================
Linkage/JJ
analysis/NN
has/VBZ
been/VBN
extremely/RB
useful/JJ
in/IN
the/DT
identification/NN
of/IN
genes/NNS
responsible/JJ
for/IN
diseases/NNS
with/IN
simple/JJ
Mendelian/JJ
inheritance/VBP
such/JJ
as/IN
cystic/JJ
fibrosis/NN
(/(
Rommens/NNS
etal./FW
,/,
1989/CD
)/)
./.
====================
Since/IN
complex/NN
diseases/NNS
are/VBP
likely/JJ
to/TO
be/VB
influenced/VBN
by/IN
the/DT
factors/NNS
such/JJ
as/IN
genetic/JJ
heterogeneity/NN
,/,
phenocopies/NNS
,/,
incomplete/JJ
penetrance/NN
,/,
genotype-by-environment/JJ
interactions/NNS
,/,
and/CC
multilocus/JJ
effects/NNS
,/,
the/DT
application/NN
of/IN
linkage/NN
analysis/NN
to/TO
complex/NN
diseases/NNS
has/VBZ
been/VBN
much/RB
less/RBR
successful/JJ
./.
====================
Complex/NN
diseases/NNS
are/VBP
likely/JJ
to/TO
be/VB
influenced/VBN
by/IN
multiple/JJ
genes/NNS
of/IN
small/JJ
effect/NN
(/(
Elston/NN
,/,
1995/CD
)/)
./.
====================
Association/NN
studies/NNS
provide/VBP
the/DT
most/JJS
powerful/JJ
approach/NN
to/TO
identify/VB
such/JJ
genes/NNS
underlying/VBG
complex/NN
traits/VBZ
(/(
Risch/NN
and/CC
====================
Merikangas/NNS
,/,
1996/CD
)/)
./.
====================
Genetic/JJ
association/NN
studies/NNS
investigate/VBP
whether/IN
there/EX
is/VBZ
a/DT
relationship/NN
between/IN
a/DT
“/JJ
genetic/JJ
marker/NN
”/CD
and/CC
the/DT
frequency/NN
or/CC
severity/NN
of/IN
a/DT
particular/JJ
trait/NN
./.
====================
Risch/DT
and/CC
Merikangas/NNS
(/(
1996/CD
)/)
have/VBP
shown/VBN
that/IN
association/NN
studies/NNS
can/MD
be/VB
a/DT
very/RB
powerful/JJ
approach/NN
to/TO
find/VB
genetic/JJ
determinants/NNS
of/IN
a/DT
complex/NN
disorder/NN
./.
====================
Genetic/JJ
association/NN
studies/NNS
have/VBP
been/VBN
applied/VBN
in/IN
a/DT
variety/NN
of/IN
complex/NN
human/JJ
diseases/NNS
such/JJ
as/IN
cancer/NN
,/,
alcoholism/NN
,/,
pulmonary/JJ
disease/NN
,/,
heart/NN
disease/NN
,/,
diabetes/VBZ
and/CC
Alzheimer/NN
disease/NN
(/(
Silverman/JJ
and/CC
Palmer/NN
,/,
2000/CD
;/:
Risch/NNP
and/CC
Merikangas/NNS
,/,
1996/CD
;/:
Chakravarti/NNP
,/,
1999/CD
)/)
./.
====================
Different/JJ
experimental/JJ
designs/NNS
can/MD
be/VB
used/VBN
to/TO
conduct/VB
genetic/JJ
association/NN
studies/NNS
./.
====================
Cohort/NN
studies/NNS
prospectively/RB
assemble/JJ
a/DT
group/NN
of/IN
individuals/NNS
,/,
and/CC
then/RB
follow/VBP
them/PRP
to/TO
determine/VB
the/DT
frequency/NN
of/IN
developing/VBG
disease/NN
./.
====================
Cohort/NN
studies/NNS
investigate/VBP
the/DT
frequency/NN
of/IN
the/DT
DNA/NN
variant/NN
in/IN
the/DT
entire/JJ
cohort/NN
for/IN
the/DT
estimation/NN
of/IN
risk/NN
ratio/NN
and/CC
predictive/JJ
values/NNS
./.
====================
Cohort/NN
studies/NNS
are/VBP
labor/JJ
intensive/JJ
and/CC
costly/RB
./.
====================
However/RB
,/,
phenotype/NN
may/MD
be/VB
more/RBR
clearly/RB
defined/VBN
for/IN
genetic/JJ
analysis/NN
through/IN
the/DT
use/NN
of/IN
longitudinal/JJ
data/NNS
due/IN
to/TO
the/DT
ability/NN
to/TO
observe/VB
the/DT
natural/JJ
history/NN
of/IN
the/DT
disease/NN
and/CC
potentially/RB
significant/JJ
comorbidities/NNS
./.
====================
This/DT
is/VBZ
an/DT
important/JJ
issue/NN
in/IN
complex/NN
human/JJ
disease/NN
since/IN
research/NN
into/IN
such/JJ
diseases/NNS
can/MD
be/VB
complicated/VBN
by/IN
phenotype/NN
heterogeneity/NN
./.
====================
Cohort/NN
studies/NNS
are/VBP
potentially/RB
less/RBR
prone/NN
to/TO
ascertainment/VB
bias/NNS
than/IN
are/VBP
case-control/JJ
studies/NNS
,/,
although/IN
geographic/JJ
and/CC
population/NN
factors/NNS
must/MD
be/VB
examined/VBN
explicitly/RB
./.
====================
Case-control/NN
designs/NNS
for/IN
genetic/JJ
association/NN
studies/NNS
are/VBP
not/RB
different/JJ
in/IN
conception/NN
from/IN
the/DT
case-control/JJ
designs/NNS
that/DT
have/VBP
been/VBN
well/RB
developed/VBN
for/IN
use/NN
in/IN
epidemiological/JJ
methods/NNS
(/(
Romero/NNP
eta/./FW
,/,
2002/CD
)/)
./.
====================
Case-control/NN
studies/NNS
examine/VBP
the/DT
frequency/NN
of/IN
a/DT
DNA/NN
variant/NN
in/IN
individuals/NNS
affected/VBD
by/IN
a/DT
disease/NN
(/(
cases/NNS
)/)
and/CC
in/IN
those/DT
not/RB
affected/VBN
by/IN
the/DT
disorder/NN
(/(
controls/NNS
)/)
./.
====================
Genetic/JJ
association/NN
studies/NNS
have/VBP
been/VBN
mostly/RB
performed/VBN
in/IN
a/DT
case-control/JJ
setting/VBG
with/IN
unrelated/JJ
affected/VBN
subjects/NNS
compared/VBN
with/IN
unrelated/JJ
unaffected/JJ
subjects/NNS
./.
====================
Significant/JJ
differences/NNS
in/IN
allele/NN
frequencies/NNS
or/CC
genotype/NN
frequencies/NNS
between/IN
cases/NNS
and/CC
controls/VBZ
are/VBP
taken/VBN
as/IN
evidence/NN
for/IN
involvement/NN
of/IN
an/DT
allele/NN
or/CC
genotype/NN
in/IN
disease/NN
susceptibility/NN
./.
====================
Case-control/NN
studies/NNS
are/VBP
potentially/RB
susceptible/JJ
to/TO
bias/NNS
if/IN
case/NN
and/CC
controls/VBZ
are/VBP
not/RB
in/IN
fact/NN
comparable/JJ
./.
====================
One/CD
====================
source/NN
of/IN
this/DT
bias/NNS
arises/VBZ
due/JJ
to/TO
population/NN
stratification/NN
./.
====================
Population/NN
stratification/NN
occurs/VBZ
when/WRB
the/DT
differences/NNS
in/IN
gene/NN
frequency/NN
are/VBP
wholly/RB
or/CC
partially/RB
attributable/JJ
to/TO
inherent/JJ
underlying/VBG
population/NN
structures/NNS
between/IN
cases/NNS
and/CC
controls/VBZ
rather/RB
than/IN
to/TO
association/NN
between/IN
disease/NN
and/CC
gene/NN
./.
====================
Case-control/NN
studies/NNS
are/VBP
also/RB
susceptible/JJ
to/TO
a/DT
spurious/JJ
association/NN
by/IN
a/DT
false-positive/JJ
result/NN
due/IN
to/TO
chance/VB
./.
====================
The/DT
problem/NN
is/VBZ
particularly/RB
acute/JJ
for/IN
studies/NNS
involving/VBG
a/DT
large/JJ
number/NN
of/IN
markers/NNS
,/,
such/JJ
as/IN
are/VBP
used/VBN
in/IN
regional/JJ
or/CC
genome-wide/NN
association/NN
studies/NNS
./.
====================
This/DT
association/NN
will/MD
be/VB
less/RBR
likely/JJ
if/IN
a/DT
very/RB
stringent/JJ
threshold/JJ
for/IN
significance/NN
is/VBZ
met/JJ
./.
====================
Risch/DT
and/CC
Merikangas/NNS
(/(
1996/CD
)/)
suggest/VBP
a/DT
Bonferroni/NNP
correction/NN
with/IN
a/DT
p-value/JJ
of/IN
5x1/NN
O/NN
'/``
8/CD
to/TO
demonstrate/VB
a/DT
significant/JJ
association/NN
if/IN
one/CD
million/NN
SNPs/NNS
(/(
single/JJ
nucleotide/NN
polymorphisms/NNS
)/)
were/VBD
typed/VBN
across/IN
the/DT
genome/NN
./.
====================
While/IN
Bonferroni/NNP
corrections/NNS
(/(
Bonferroni/NNP
,/,
1936/CD
)/)
are/VBP
often/RB
used/VBN
when/WRB
multiple/JJ
associations/NNS
are/VBP
measured/VBN
in/IN
a/DT
study/NN
,/,
there/EX
are/VBP
some/DT
features/NNS
of/IN
a/DT
genetic/JJ
association/NN
study/NN
which/WDT
make/VBP
it/PRP
unattractive/JJ
./.
====================
Bonferroni/DT
corrections/NNS
are/VBP
estimated/VBN
by/IN
dividing/VBG
the/DT
type/NN
I/CD
error/NN
rate/NN
(/(
a/DT
)/)
by/IN
the/DT
number/NN
of/IN
tests/NNS
performed/VBN
;/:
after/IN
this/DT
procedure/NN
,/,
a/DT
test/NN
is/VBZ
significant/JJ
only/RB
if/IN
the/DT
p-value/JJ
is/VBZ
less/RBR
than/IN
this/DT
adjusted/JJ
type/NN
I/CD
error/NN
rate/NN
./.
====================
However/RB
,/,
with/IN
the/DT
number/NN
of/IN
tests/NNS
done/NN
in/IN
a/DT
typical/JJ
genetic/JJ
association/NN
study/NN
,/,
it/PRP
is/VBZ
clear/JJ
that/IN
the/DT
Bonferroni/NN
correction/NN
can/MD
significantly/RB
lower/JJR
power/JJR
for/IN
detecting/VBG
true/JJ
association/NN
./.
====================
The/DT
correction/NN
also/RB
does/VBZ
not/RB
account/VB
for/IN
the/DT
fact/NN
that/IN
often/RB
the/DT
test/NN
statistics/NNS
of/IN
markers/NNS
located/JJ
in/IN
near/JJ
proximity/NN
are/VBP
not/RB
independent/JJ
test/NN
and/CC
are/VBP
,/,
in/IN
fact/NN
highly/RB
correlated/VBD
./.
====================
For/IN
instance/NN
,/,
investigating/VBG
2/CD
SNPs/NNS
that/DT
are/VBP
50/CD
kb/NN
apart/VBP
are/VBP
likely/JJ
highly/RB
correlated/VBD
due/JJ
to/TO
linkage/NN
disequilibrium/NN
./.
====================
To/TO
address/VB
this/DT
issue/NN
,/,
Kaplan/NN
et/FW
al/JJ
./.
====================
(/(
1997/CD
)/)
and/CC
McIntyre/NN
et/FW
al/JJ
./.
====================
(/(
2000/CD
)/)
have/VBP
proposed/VBN
a/DT
Monte/JJ
Carlo/NN
approach/NN
for/IN
evaluating/VBG
associations/NNS
within/IN
the/DT
transmission/disequilibrium/NN
test/NN
(/(
TDT/NN
)/)
construct/NN
for/IN
a/DT
single/JJ
locus/NN
and/CC
multilocus/JJ
tests/NNS
,/,
respectively/RB
./.
====================
The/DT
case-control/JJ
study/NN
remains/VBZ
a/DT
popular/JJ
approach/NN
in/IN
genetic/JJ
epidemiology/NN
since/IN
case-control/JJ
studies/NNS
are/VBP
economically/RB
and/CC
statistically/RB
efficient/JJ
./.
====================
Even/RB
though/IN
ascertainment/JJ
of/IN
disease/NN
,/,
selection/NN
of/IN
controls/NNS
,/,
and/CC
measurement/NN
of/IN
exposure/NN
present/JJ
substantial/JJ
difficulties/NNS
in/IN
most/JJS
case-control/JJ
studies/NNS
,/,
a/DT
large/JJ
body/NN
of/IN
epidemiologic/JJ
theory/JJ
provides/VBZ
guidance/NN
to/TO
meet/VB
these/DT
challenges/NNS
./.
====================
Bias/NNS
arising/VBG
from/IN
population/NN
stratification/NN
should/MD
be/VB
mitigated/JJ
by/IN
proper/JJ
design/NN
and/CC
analysis/NN
of/IN
case-control/JJ
studies/NNS
and/CC
by/IN
new/JJ
statistical/JJ
methods/NNS
such/JJ
as/IN
genomic/JJ
control/NN
./.
====================
This/DT
method/NN
,/,
proposed/VBN
by/IN
Devlin/NN
and/CC
Roeder/NNP
(/(
1999/CD
)/)
,/,
does/VBZ
not/RB
require/VB
information/NN
about/IN
the/DT
genealogy/NN
of/IN
the/DT
population/NN
and/CC
corrects/NNS
for/IN
population/NN
heterogeneity/NN
,/,
poor/JJ
choice/NN
of/IN
controls/NNS
,/,
and/CC
cryptic/JJ
relatedness/NN
of/IN
cases/NNS
./.
====================
The/DT
validity/NN
of/IN
genetic/JJ
association/NN
studies/NNS
depends/VBZ
on/IN
the/DT
selection/NN
of/IN
appropriate/JJ
controls/NNS
since/IN
misclassification/NN
====================
of/IN
controls/NNS
leads/VBZ
to/TO
a/DT
false-negative/JJ
result/NN
./.
====================
Controls/NNS
may/MD
be/VB
pre-symptomatic/JJ
or/CC
asymptomatic/JJ
instead/RB
of/IN
disease-free/JJ
for/IN
disease/NN
such/JJ
as/IN
stroke/JJ
which/WDT
tends/VBZ
to/TO
have/VB
an/DT
advanced/JJ
age/NN
of/IN
onset/NN
./.
====================
Small/JJ
cerebral/JJ
infarctions/NNS
are/VBP
visible/JJ
only/RB
in/IN
CT/NN
scans/NNS
./.
====================
So/RB
,/,
the/DT
subjects/NNS
classified/VBN
as/IN
controls/NNS
may/MD
have/VB
asymptomatic/JJ
disease/NN
./.
====================
Therefore/RB
,/,
as/IN
with/IN
standard/JJ
epidemiologic/JJ
studies/NNS
,/,
phenotypic/JJ
characterizations/NNS
of/IN
controls/NNS
and/CC
cases/NNS
are/VBP
crucial/JJ
./.
====================
Care/NN
and/CC
attention/NN
in/IN
the/DT
design/NN
,/,
such/JJ
as/IN
having/VBG
older/JJR
controls/NNS
(/(
i.e./FW
,/,
outside/IN
of/IN
the/DT
risk/NN
profile/NN
)/)
can/MD
mitigate/VB
this/DT
bias/NNS
./.
====================
Unlike/IN
risk/NN
factors/NNS
in/IN
traditional/JJ
case-control/JJ
studies/NNS
,/,
genes/NNS
do/VBP
not/RB
have/VB
the/DT
potential/JJ
for/IN
risk/NN
factor/NN
recall/NN
bias/NNS
./.
====================
Population/NN
stratification/NN
is/VBZ
a/DT
form/NN
of/IN
confounding/VBG
(/(
Wacholder/NN
et/FW
al./FW
,/,
2000/CD
)/)
that/WDT
may/MD
cause/VB
spurious/JJ
associations/NNS
in/IN
a/DT
case-control/JJ
study/NN
when/WRB
allelic/JJ
frequencies/NNS
vary/VBP
across/IN
subpopulations/NNS
within/IN
the/DT
study/NN
sample/NN
./.
====================
In/IN
association/NN
studies/NNS
,/,
the/DT
standard/JJ
methods/NNS
for/IN
dealing/VBG
with/IN
potential/JJ
confounding/VBG
effects/NNS
are/VBP
matching/VBG
====================
and/CC
statistical/JJ
adjustment/JJ
./.
====================
In/IN
association/NN
studies/NNS
using/VBG
DNA/NN
pools/NNS
from/IN
many/JJ
individuals/NNS
,/,
significant/JJ
causal/JJ
disease/NN
associations/NNS
may/MD
not/RB
be/VB
distinguished/VBN
from/IN
associations/NNS
due/JJ
to/TO
the/DT
differences/NNS
in/IN
confounding/VBG
factors/NNS
between/IN
cases/NNS
and/CC
controls/VBZ
./.
====================
Thus/RB
,/,
matching/VBG
by/IN
confounding/VBG
factors/NNS
prior/JJ
to/TO
DNA/NN
pooling/NN
is/VBZ
essential/JJ
./.
====================
Population/NN
stratification/NN
may/MD
be/VB
solved/VBN
by/IN
using/VBG
matched/VBN
case-control/JJ
designs/NNS
which/WDT
match/VBP
controls/NNS
to/TO
cases/NNS
on/IN
potential/JJ
confounding/VBG
factors/NNS
such/JJ
as/IN
age/NN
,/,
sex/NN
,/,
and/CC
ethnicity/NN
,/,
etc/JJ
./.
====================
That/DT
is/VBZ
,/,
DNA/NN
pools/NNS
needs/VBZ
to/TO
be/VB
matched/VBN
to/TO
have/VB
similar/JJ
socio-demographic/JJ
composition/NN
to/TO
minimize/VB
the/DT
risk/NN
of/IN
spurious/JJ
associations/NNS
due/JJ
to/TO
confounding/VBG
./.
====================
Then/RB
,/,
allele­/DT
frequency/NN
estimates/NNS
in/IN
the/DT
matched/VBN
DNA/NN
pools/NNS
will/MD
give/VB
a/DT
more/RBR
reliable/JJ
indication/NN
of/IN
causal/JJ
disease/NN
association/NN
./.
====================
Statistical/JJ
methods/NNS
are/VBP
proposed/VBN
to/TO
adequately/RB
control/NN
for/IN
population/NN
stratification/NN
(/(
Devlin/NN
and/CC
Roeder/NN
,/,
1999/CD
;/:
Pritchard/NN
and/CC
Rosenberg/NN
,/,
1999/CD
;/:
Pritchard/NN
et/FW
al./FW
,/,
2000/CD
)/)
./.
====================
When/WRB
a/DT
disorder/NN
has/VBZ
known/VBN
risk/NN
factors/NNS
,/,
it/PRP
might/MD
be/VB
desirable/JJ
to/TO
construct/VB
multiple/JJ
pools/NNS
so/RB
that/IN
pools/VBZ
differ/VBP
in/IN
the/DT
level/NN
of/IN
exposure/NN
to/TO
the/DT
risk/NN
factors/NNS
./.
====================
Use/NN
of/IN
multiple/JJ
pools/NNS
incorporating/VBG
risk/NN
factors/NNS
might/MD
increase/VB
the/DT
power/NN
to/TO
detect/VB
an/DT
allelic/JJ
association/NN
with/IN
disease/NN
./.
====================
However/RB
,/,
it/PRP
can/MD
be/VB
argued/VBN
that/IN
the/DT
use/NN
of/IN
multiple/JJ
pools/NNS
can/MD
be/VB
avoided/VBN
by/IN
using/VBG
the/DT
risk/NN
factors/NNS
as/IN
covariates/VBZ
in/IN
the/DT
statistical/JJ
analysis/NN
at/IN
the/DT
second/JJ
stage/NN
since/IN
DNA/NN
pooling/NN
is/VBZ
used/VBN
as/IN
a/DT
screen/NN
to/TO
be/VB
followed/VBN
by/IN
individual/JJ
genotyping/VBG
./.
====================
Family-based/JJ
case-control/JJ
designs/NNS
can/MD
be/VB
used/VBN
to/TO
solve/VB
the/DT
stratification/NN
problem/NN
./.
====================
That/DT
is/VBZ
,/,
stratification/NN
problem/NN
can/MD
be/VB
solved/VBN
using/VBG
parents/NNS
as/IN
controls/NNS
or/CC
using/VBG
====================
unaffected/JJ
sibs/NNS
as/IN
controls/NNS
./.
====================
However/RB
,/,
family-based/VBD
case-control/JJ
designs/NNS
are/VBP
more/RBR
expensive/JJ
than/IN
the/DT
case-control/JJ
designs/NNS
using/VBG
controls/NNS
that/DT
are/VBP
unrelated/JJ
to/TO
the/DT
cases/NNS
./.
====================
Family-based/JJ
designs/NNS
will/MD
have/VBP
less/RBR
power/JJR
compared/VBN
to/TO
a/DT
well-designed/JJ
study/NN
involving/VBG
unrelated/JJ
controls/NNS
./.
====================
Genetic/JJ
case-control/JJ
study/NN
still/RB
poses/VBZ
great/JJ
challenges/NNS
./.
====================
One/CD
of/IN
the/DT
difficulties/NNS
is/VBZ
to/TO
obtain/VB
the/DT
large/JJ
number/NN
of/IN
genotypes/NNS
needed/VBD
./.
====================
Additionally/RB
,/,
sample/JJ
sizes/NNS
of/IN
hundreds/VBZ
or/CC
even/RB
thousands/VBZ
of/IN
subjects/NNS
may/MD
be/VB
needed/VBN
to/TO
achieve/VB
statistical/JJ
power/JJR
to/TO
detect/VB
loci/NNS
with/IN
modest/JJS
effect/NN
size/NN
./.
====================
Genetic/JJ
association/NN
studies/NNS
using/VBG
a/DT
set/NN
of/IN
SNPs/NNS
that/DT
covers/VBZ
the/DT
human/JJ
genome/NN
densely/RB
would/MD
be/VB
very/RB
expensive/JJ
,/,
and/CC
beyond/IN
the/DT
reach/NN
of/IN
most/JJS
laboratories/NNS
even/RB
though/IN
the/DT
cost/JJ
of/IN
large-scale/JJ
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNP/NN
)/)
determination/NN
dropped/VBD
dramatically/RB
in/IN
recent/JJ
years/NNS
./.
====================
As/IN
a/DT
result/NN
,/,
the/DT
development/NN
of/IN
innovative/JJ
study/NN
designs/VBZ
that/DT
reduce/VBP
the/DT
cost/JJ
is/VBZ
warranted/VBN
./.
====================
Haplotype-tagging/VBG
SNPs/NNS
and/CC
DNA/NN
pooling/NN
have/VBP
potential/JJ
to/TO
reduce/VB
the/DT
cost/JJ
barriers/NNS
of/IN
the/DT
genetic/JJ
association/NN
study/NN
./.
====================
Botstein/DT
and/CC
Risch/NN
(/(
2003/CD
)/)
provide/VBP
an/DT
excellent/JJ
review/NN
for/IN
the/DT
comparison/NN
of/IN
genome-wide/NN
haplotype/NN
map-based/VBD
versus/CC
sequenced-based/VBN
strategies/NNS
./.
====================
The/DT
use/NN
of/IN
haplotype-tagging/VBG
SNPs/NNS
is/VBZ
a/DT
map-based/VBN
approach/NN
while/IN
DNA/NN
pooling/NN
is/VBZ
a/DT
sequenced-based/VBN
approach/NN
./.
====================
A/DT
comprehensive/JJ
map-based/VBD
approach/NN
may/MD
require/VB
genotyping/VBG
10-fold/JJ
more/RBR
SNPs/NNS
than/IN
a/DT
sequence­/JJ
based/VBN
approach/NN
(/(
500,000-1,000,000/CD
for/IN
map-/JJ
based/VBN
versus/CC
50,000-100,000/CD
for/IN
sequenced-based/VBN
)/)
./.
====================
Bostein/DT
and/CC
Risch/NN
(/(
2003/CD
)/)
suggest/VBP
a/DT
sequence-based/VBN
approach/NN
for/IN
the/DT
initial/JJ
stage/NN
of/IN
a/DT
major/JJ
program/NN
aimed/VBD
at/IN
genome­/JJ
wide/JJ
association/NN
studies/NNS
./.
====================
Bansal/NN
etal/JJ
./.
====================
(/(
2002/CD
)/)
demonstrate/VBP
the/DT
potential/JJ
of/IN
a/DT
sequence-based/VBN
DNA/NN
pooling/NN
techniques/NNS
and/CC
their/PRP$
associated/VBN
technologies/NNS
as/IN
an/DT
initial/JJ
screen/NN
in/IN
the/DT
search/NN
for/IN
genetic/JJ
association/NN
./.
====================
The/DT
use/NN
of/IN
DNA/NN
pooling/NN
technique/NN
has/VBZ
been/VBN
proposed/VBN
as/IN
a/DT
means/NN
of/IN
reducing/VBG
the/DT
number/NN
of/IN
genotyping/VBG
reactions/NNS
required/VBN
,/,
hence/RB
reducing/VBG
the/DT
cost/JJ
of/IN
large-scale/JJ
case-control/JJ
association/NN
studies/NNS
./.
====================
DNA/NN
pooling/NN
is/VBZ
a/DT
powerful/JJ
and/CC
efficient/JJ
tool/NN
for/IN
high/JJ
throughput/NN
association/NN
analysis/NN
./.
====================
DNA/NN
pooling/NN
allows/VBZ
measurement/NN
of/IN
allele/NN
frequencies/NNS
in/IN
groups/NNS
(/(
or/CC
pools/NNS
)/)
of/IN
individuals/NNS
,/,
thereby/RB
reducing/VBG
the/DT
number/NN
of/IN
PCR/NN
reactions/NNS
and/CC
genotyping/VBG
assays/NNS
dramatically/RB
./.
====================
Therefore/RB
,/,
the/DT
use/NN
of/IN
DNA/NN
pooling/NN
====================
can/MD
significantly/RB
reduce/VB
the/DT
number/NN
of/IN
genotyping/VBG
reactions/NNS
required/VBN
;/:
hence/RB
reducing/VBG
the/DT
cost/JJ
of/IN
large-/NN
scale/NN
case-control/JJ
association/NN
studies/NNS
,/,
and/CC
offering/VBG
an/DT
approach/NN
to/TO
this/DT
economic/JJ
impasse/VBP
./.
====================
Furthermore/RB
,/,
DNA/NN
pooling/NN
can/MD
be/VB
an/DT
extremely/RB
effective/JJ
method/NN
for/IN
conserving/VBG
precious/JJ
DNA/NN
./.
====================
The/DT
most/JJS
powerful/JJ
methods/NNS
for/IN
detecting/VBG
the/DT
association/NN
between/IN
a/DT
marker/NN
and/CC
a/DT
phenotype/NN
require/VBP
individual/JJ
genotyping/VBG
./.
====================
Experimental/JJ
savings/NNS
can/MD
be/VB
achieved/VBN
by/IN
testing/VBG
allele/NN
frequency/NN
differences/NNS
between/IN
DNA/NN
pools/NNS
chosen/NN
by/IN
phenotypic/JJ
value/NN
(/(
Darvasi/NNP
and/CC
Soller/NN
,/,
1994/CD
;/:
Barcellos/NN
etal/JJ
,/,
1997/CD
)/)
./.
====================
In/IN
DNA/NN
pooling/NN
,/,
the/DT
equal/JJ
amounts/NNS
of/IN
DNA/NN
from/IN
each/DT
subject/JJ
are/VBP
used/VBN
to/TO
create/VB
a/DT
pool/NN
to/TO
estimate/VB
the/DT
allele/NN
frequency/NN
./.
====================
That/DT
is/VBZ
,/,
DNA/NN
of/IN
individuals/NNS
is/VBZ
mixed/VBN
together/RB
to/TO
generate/VB
a/DT
pool/NN
before/IN
estimating/VBG
allele/NN
frequencies/NNS
./.
====================
In/IN
general/JJ
,/,
one/CD
pool/NN
is/VBZ
created/VBN
out/RP
of/IN
all/DT
cases/NNS
and/CC
a/DT
second/JJ
out/RP
of/IN
all/DT
controls/NNS
in/IN
a/DT
case-control/JJ
study/NN
./.
====================
Allele/DT
frequencies/NNS
are/VBP
then/RB
estimated/VBN
in/IN
each/DT
pool/NN
and/CC
compared/VBN
directly/RB
between/IN
two/CD
pools/NNS
./.
====================
Various/JJ
methods/NNS
have/VBP
been/VBN
used/VBN
for/IN
allele/NN
frequency/NN
estimation/NN
,/,
including/VBG
mass/NN
spectrometry/NN
,/,
denaturing/VBG
high-performance/VBP
liquid/JJ
chromatography/NN
(/(
HPLC/NN
)/)
,/,
and/CC
photo-lithography/NN
./.
====================
Whatever/RB
the/DT
method/NN
of/IN
estimating/VBG
allele/NN
frequency/NN
is/VBZ
used/VBN
,/,
allele/NN
frequencies/NNS
are/VBP
estimated/VBN
in/IN
each/DT
DNA/NN
pool/NN
by/IN
quantifying/VBG
the/DT
relative/JJ
amounts/NNS
of/IN
DNA/NN
products/NNS
representing/VBG
each/DT
allele/NN
./.
====================
In/IN
DNA/NN
pooling/NN
,/,
allele/NN
frequency/NN
is/VBZ
measured/VBN
in/IN
a/DT
large/JJ
number/NN
of/IN
SNP/NN
markers/NNS
in/IN
each/DT
of/IN
the/DT
pools/NNS
as/IN
an/DT
efficient/JJ
screen/NN
to/TO
enrich/JJ
for/IN
SNPs/NNS
with/IN
significant/JJ
allele/NN
frequency/NN
differences/NNS
(/(
Bansal/NN
et/FW
al./FW
,/,
2002/CD
)/)
./.
====================
The/DT
SNPs/NNS
with/IN
the/DT
large/JJ
allele-frequency/NN
differences/NNS
in/IN
the/DT
pooled/JJ
data/NNS
are/VBP
then/RB
selected/VBN
for/IN
individual/JJ
genotyping/VBG
./.
====================
The/DT
pooled/JJ
genotyping/VBG
step/NN
reduces/VBZ
the/DT
number/NN
of/IN
SNPs/NNS
that/DT
must/MD
be/VB
individually/RB
genotyped/VBD
to/TO
confirm/VB
allele-frequency/NN
differences/NNS
between/IN
cases/NNS
and/CC
controls/VBZ
./.
====================
The/DT
larger/JJR
the/DT
sample/NN
,/,
the/DT
greater/JJR
the/DT
saving/JJ
,/,
so/RB
that/IN
the/DT
design/NN
with/IN
minimal/JJ
genotyping/VBG
would/MD
involve/VB
comparing/VBG
just/RB
two/CD
pools/NNS
,/,
each/DT
containing/VBG
DNA/NN
from/IN
numerous/JJ
individuals/NNS
./.
====================
These/DT
two/CD
pools/NNS
could/MD
be/VB
constituted/VBN
from/IN
cases/NNS
and/CC
controls/VBZ
for/IN
a/DT
disease/NN
trait/VBP
,/,
or/CC
from/IN
individuals/NNS
with/IN
trait/NN
values/NNS
at/IN
the/DT
two/CD
extremes/NNS
of/IN
a/DT
quantitative/JJ
trait/NN
./.
====================
For/IN
the/DT
quantitative/JJ
traits/VBZ
such/JJ
as/IN
blood/NN
pressure/NN
and/CC
cholesterol/NN
levels/NNS
,/,
Bader/NN
et/FW
al/JJ
./.
====================
(/(
2001/CD
)/)
provide/VBP
power/JJ
estimates/NNS
for/IN
two/CD
pooled/JJ
DNA/NN
designs/NNS
which/WDT
classify/VBP
the/DT
individuals/NNS
as/IN
affected/VBN
or/CC
unaffected/JJ
,/,
analogous/JJ
to/TO
a/DT
case-control/JJ
design/NN
./.
====================
The/DT
optimal/JJ
design/NN
for/IN
the/DT
quantitative/JJ
phenotypes/NNS
is/VBZ
to/TO
pool/NN
the/DT
top/NN
and/CC
bottom/CC
27/CD
%/NN
of/IN
individuals/NNS
./.
====================
This/DT
optimal/JJ
design/NN
requires/VBZ
a/DT
sample/JJ
size/NN
only/RB
1.24/CD
times/NNS
larger/JJR
than/IN
that/DT
required/VBD
for/IN
individual/JJ
genotyping/VBG
when/WRB
we/PRP
ignore/VBP
the/DT
experimental/JJ
measurement/NN
error/NN
./.
====================
When/WRB
a/DT
measurement/NN
error/NN
is/VBZ
included/VBN
,/,
the/DT
pooled/JJ
====================
DNA/NN
association/NN
test/NN
serves/VBZ
well/RB
as/IN
a/DT
pre-screen/JJ
to/TO
identify/VB
candidate/NN
markers/NNS
which/WDT
then/RB
proceed/VBD
to/TO
individual/JJ
genotyping/VBG
./.
====================
This/DT
DNA/NN
pooling/NN
strategy/NN
can/MD
still/RB
provide/VBP
a/DT
substantial/JJ
savings/NNS
over/IN
individual/JJ
genotyping/VBG
./.
====================
There/EX
are/VBP
disparate/JJ
recommendations/NNS
on/IN
the/DT
pool/NN
sizes/NNS
in/IN
DNA/NN
pooling/NN
./.
====================
While/IN
Barratt/NN
etal/JJ
./.
====================
(/(
2002/CD
)/)
suggest/VBP
the/DT
pool/NN
sizes/NNS
of/IN
50/CD
or/CC
fewer/JJR
,/,
Mohlke/NNP
etal/JJ
./.
====================
(/(
2002/CD
)/)
and/CC
Le/NN
Hellard/JJ
etal/JJ
./.
====================
(/(
2002/CD
)/)
suggest/VBP
larger/JJR
pool/NN
size/NN
of/IN
up/RB
to/TO
500/CD
cases/NNS
and/CC
500/CD
controls/NNS
./.
====================
Feng/NN
et/FW
al/JJ
./.
====================
(/(
2004/CD
)/)
thinks/VBZ
the/DT
larger/JJR
pool/NN
sizes/NNS
are/VBP
preferable/JJ
since/IN
the/DT
quality/NN
of/IN
frequency/NN
estimates/NNS
does/VBZ
not/RB
seem/VB
to/TO
degrade/VB
with/IN
larger/JJR
pool/NN
size/NN
./.
====================
Effect/JJ
of/IN
pool/NN
sizes/NNS
on/IN
DNA/NN
pooling/NN
needs/VBZ
to/TO
be/VB
investigated/VBN
./.
====================
There/EX
are/VBP
some/DT
potential/JJ
error/JJ
sources/NNS
in/IN
the/DT
stages/NNS
of/IN
DNA/NN
quantification/NN
and/CC
formation/NN
of/IN
pools/NNS
(/(
Barratt/NN
et/FW
al./FW
,/,
2002/CD
)/)
./.
====================
One/CD
of/IN
the/DT
potential/JJ
error/JJ
sources/NNS
is/VBZ
that/DT
alleles/NNS
with/IN
different/JJ
sequences/NNS
may/MD
not/RB
be/VB
amplified/VBN
equally/RB
in/IN
the/DT
competitive/JJ
reaction/NN
./.
====================
Many/JJ
high-throughput/JJ
genotyping/VBG
platforms/NNS
measure/VB
the/DT
amount/NN
of/IN
each/DT
allele/NN
from/IN
competitive/JJ
amplification/NN
reaction/NN
,/,
and/CC
determine/VBP
the/DT
genotype/NN
based/VBN
on/IN
the/DT
abundance/NN
of/IN
alleles/NNS
./.
====================
A/DT
standard/JJ
procedure/NN
is/VBZ
to/TO
genotype/NN
some/DT
heterozygotes/NNS
individually/RB
using/VBG
competitive/JJ
reaction/NN
and/CC
then/RB
to/TO
estimate/VB
the/DT
average/NN
relative/JJ
speed/RB
of/IN
amplification/NN
reaction/NN
from/IN
the/DT
experimentally/RB
./.
====================
If/IN
each/DT
allele/NN
of/IN
an/DT
SNP/NN
site/NN
is/VBZ
equally/RB
represented/VBN
in/IN
the/DT
assay/NN
,/,
the/DT
ratio/NN
(/(
k/NN
)/)
of/IN
the/DT
amplifications/NNS
of/IN
competing/VBG
alleles/NNS
would/MD
be/VB
one/CD
./.
====================
The/DT
frequency/NN
of/IN
allele/NN
A/DT
in/IN
a/DT
pool/NN
can/MD
be/VB
estimated/VBN
more/RBR
accurately/RB
as/IN
A//JJ
(/(
A+k/NN
•/CD
B/NN
)/)
,/,
where/WRB
A/DT
and/CC
B/NN
are/VBP
the/DT
measured/VBN
abundance/NN
of/IN
alleles/NNS
corresponding/VBG
to/TO
two/CD
polymorphic/JJ
alleles/NNS
at/IN
the/DT
SNP/NN
locus/NN
./.
====================
Another/DT
potential/JJ
error/JJ
sources/NNS
are/VBP
due/JJ
to/TO
unequal/JJ
amounts/NNS
of/IN
DNA/NN
per/IN
individual/JJ
and/CC
due/JJ
to/TO
experimental/JJ
errors/NNS
./.
====================
The/DT
foundation/NN
of/IN
successful/JJ
DNA/NN
pooling/NN
association/NN
test/NN
is/VBZ
a/DT
precise/JJ
and/CC
accurate/VBP
estimation/NN
of/IN
allele/NN
frequency/NN
./.
====================
Tang/NN
et/FW
al/JJ
./.
====================
(/(
2004/CD
)/)
show/VBP
that/IN
the/DT
SNP/NN
allele/NN
frequency/NN
estimates/NNS
from/IN
pooled/JJ
analysis/NN
are/VBP
comparable/JJ
to/TO
those/DT
from/IN
individual/JJ
genotyping/VBG
./.
====================
The/DT
coefficient/JJ
of/IN
determination/NN
(/(
R-square/NN
)/)
of/IN
the/DT
frequency/NN
estimates/NNS
between/IN
DNA/NN
pooling/NN
and/CC
individual/JJ
genotyping/VBG
is/VBZ
0.975/CD
using/VBG
individual/JJ
heterozygous/JJ
samples/NNS
./.
====================
The/DT
quantitative/JJ
abilities/NNS
of/IN
various/JJ
platforms/NNS
used/VBN
for/IN
estimating/VBG
allele/NN
frequencies/NNS
are/VBP
confirmed/VBN
by/IN
multiple/JJ
studies/NNS
(/(
Sham/NN
et/FW
al./FW
,/,
2002/CD
;/:
Le/NNP
Hellard/JJ
etal./FW
,/,
2002/CD
;/:
Shifman/NNP
et/FW
al./FW
,/,
2002/CD
;/:
Moskvina/NNP
etal./FW
,/,
in/IN
press/NN
)/)
./.
====================
Mohlke/JJ
etal/JJ
./.
====================
(/(
2002/CD
)/)
provide/VBP
an/DT
example/NN
of/IN
comparison/NN
of/IN
SNP/NN
allele/NN
frequency/NN
estimates/NNS
from/IN
pooled/JJ
analysis/NN
and/CC
from/IN
individual/JJ
genotyping/VBG
./.
====================
Due/IN
to/TO
the/DT
dramatic/JJ
reduction/NN
in/IN
the/DT
large-scale/JJ
SNP/NN
determination/NN
,/,
the/DT
cost/JJ
of/IN
SNP/NN
determination/NN
is/VBZ
now/RB
approximately/RB
1/CD
cent/NN
per/IN
SNP/NN
(/(
Feng/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Epidemiologic/JJ
genetic/JJ
association/NN
studies/NNS
would/MD
be/VB
still/RB
====================
prohibitively/RB
expensive/JJ
even/RB
though/IN
the/DT
genotyping/VBG
cost/JJS
has/VBZ
recently/RB
dropped/VBD
dramatically/RB
./.
====================
Feng/NN
et/FW
al/JJ
./.
====================
(/(
2004/CD
)/)
describe/VBP
that/DT
genotyping/VBG
of/IN
2/CD
million/NN
SNPs/NNS
for/IN
500/CD
cases/NNS
and/CC
500/CD
matched/VBN
controls/NNS
would/MD
cost/VB
about/RB
$/CD
20/CD
million/NN
./.
====================
When/WRB
a/DT
single/JJ
case/NN
and/CC
a/DT
single/JJ
control/NN
pools/NNS
are/VBP
used/VBN
for/IN
pooled/JJ
analysis/NN
,/,
the/DT
minor/JJ
allele/NN
frequency/NN
analysis/NN
for/IN
2/CD
million/NN
SNPs/NNS
can/MD
be/VB
obtained/VBN
at/IN
a/DT
genotyping/JJ
cost/JJ
of/IN
about/RB
$/RB
40,000/CD
./.
====================
If/IN
quadruplicate/RB
frequency/NN
estimation/NN
is/VBZ
obtained/VBN
from/IN
the/DT
single/JJ
case/NN
and/CC
control/NN
pools/NNS
,/,
genotype/NN
cost/JJ
will/MD
be/VB
approximately/RB
$/CD
160,000/CD
./.
====================
DNA/NN
pooling/NN
technique/NN
has/VBZ
the/DT
potential/JJ
to/TO
reduce/VB
the/DT
cost/JJ
barrier/NN
of/IN
the/DT
large-scale/JJ
genetic/JJ
association/NN
study/NN
./.
====================
It/PRP
is/VBZ
expected/VBN
that/DT
the/DT
differences/NNS
in/IN
allele/NN
frequencies/NNS
between/IN
cases/NNS
and/CC
controls/VBZ
may/MD
be/VB
only/RB
small/JJ
in/IN
the/DT
analysis/NN
of/IN
complex/NN
disease/NN
./.
====================
Therefore/RB
,/,
the/DT
success/NN
of/IN
DNA/NN
pooling/NN
crucially/RB
depends/VBZ
on/IN
reproducibility/NN
and/CC
high/JJ
accuracy/NN
in/IN
the/DT
estimation/NN
of/IN
allele/NN
frequencies/NNS
of/IN
cases/NNS
and/CC
controls/VBZ
./.
====================
Replicates/NNS
are/VBP
needed/VBN
for/IN
each/DT
reaction/NN
in/IN
order/NN
to/TO
achieve/VB
high/JJ
accuracy/NN
./.
====================
The/DT
most/JJS
effective/JJ
use/NN
of/IN
DNA/NN
pooling/NN
might/MD
be/VB
a/DT
two-stage/JJ
design/NN
in/IN
which/WDT
markers/NNS
that/WDT
show/VBP
evidence/NN
of/IN
association/NN
from/IN
the/DT
pooled/JJ
association/NN
are/VBP
followed/VBN
up/IN
by/IN
individual/JJ
genotyping/VBG
./.
====================
Allele/DT
frequencies/NNS
are/VBP
separately/RB
estimated/VBN
from/IN
cases/NNS
and/CC
controls/VBZ
at/IN
the/DT
first/JJ
stage/NN
,/,
and/CC
then/RB
individual/JJ
genotyping/VBG
will/MD
be/VB
done/VBN
for/IN
the/DT
selected/VBN
markers/NNS
with/IN
the/DT
large/JJ
allele-frequency/NN
differences/NNS
at/IN
the/DT
second/JJ
stage/NN
./.
====================
Thus/RB
,/,
pooling/VBG
can/MD
be/VB
used/VBN
as/IN
an/DT
efficient/JJ
and/CC
sensitive/JJ
method/NN
of/IN
screening/VBG
numerous/JJ
markers/NNS
to/TO
identify/VB
a/DT
subset/NN
of/IN
markers/NNS
for/IN
more/RBR
detailed/JJ
studies/NNS
./.
====================
A/DT
common/JJ
observation/NN
with/IN
the/DT
use/NN
of/IN
DNA/NN
pools/NNS
is/VBZ
that/DT
two/CD
alleles/NNS
at/IN
a/DT
polymorphic/JJ
SNP/NN
locus/NN
are/VBP
not/RB
amplified/VBN
in/IN
equal/JJ
amounts/NNS
in/IN
heterozygous/JJ
individuals/NNS
depending/VBG
on/IN
the/DT
design/NN
of/IN
assay/NN
./.
====================
In/IN
addition/NN
,/,
there/EX
are/VBP
pool-specific/JJ
errors/NNS
so/RB
that/IN
there/EX
is/VBZ
variation/NN
in/IN
the/DT
estimates/NNS
of/IN
allele/NN
frequencies/NNS
from/IN
different/JJ
pools/NNS
that/DT
are/VBP
from/IN
the/DT
same/JJ
individuals/NNS
./.
====================
As/IN
a/DT
result/NN
of/IN
these/DT
additional/JJ
sources/NNS
of/IN
variation/NN
,/,
the/DT
outcome/NN
of/IN
an/DT
experiment/JJ
is/VBZ
an/DT
estimated/VBN
count/NN
of/IN
alleles/NNS
rather/RB
than/IN
the/DT
usual/JJ
outcome/NN
in/IN
terms/NNS
of/IN
observed/VBN
counts/NNS
./.
====================
In/IN
the/DT
first/JJ
stage/NN
,/,
the/DT
simple/JJ
method/NN
to/TO
analyze/VB
SNP-based/JJ
case-control/JJ
association/NN
studies/NNS
using/VBG
DNA/NN
pooling/NN
is/VBZ
to/TO
multiply/JJ
the/DT
estimated/VBN
allele/NN
frequencies/NNS
by/IN
the/DT
number/NN
of/IN
chromosomes/NNS
in/IN
the/DT
pool/NN
and/CC
perform/NN
a/DT
chi-square/JJ
test/NN
./.
====================
This/DT
simple/JJ
chi-square/NN
test/NN
has/VBZ
been/VBN
used/VBN
in/IN
several/JJ
published/VBN
studies/NNS
(/(
Shifman/NN
etal./FW
,/,
2002/CD
;/:
Williams/NNS
etal./FW
,/,
2002/CD
;/:
Norton/JJ
etal./FW
,/,
2003,2004/CD
)/)
./.
====================
Visscher/RB
and/CC
Le/NN
Hellard/JJ
(/(
2003/CD
)/)
and/CC
Le/NN
Hellard/JJ
et/FW
al/JJ
./.
====================
(/(
2002/CD
)/)
show/VBP
that/IN
simply/RB
substituting/VBG
estimated/VBN
count/NN
for/IN
observed/VBN
====================
count/NN
can/MD
lead/VB
to/TO
an/DT
inflation/NN
of/IN
type/NN
1/CD
error/NN
rates/NNS
due/JJ
to/TO
unequal/JJ
amplification/NN
in/IN
DNA/NN
pooling/NN
./.
====================
Adjustment/JJ
was/VBD
made/VBN
to/TO
account/VB
for/IN
unequal/JJ
amplification/NN
by/IN
various/JJ
researchers/NNS
(/(
Mohlke/NNP
et/FW
al/JJ
./.
====================
2002/CD
;/:
Yang/NNP
et/FW
al./FW
,/,
2005/CD
;/:
Visscherand/CC
Le/NNP
Hellard/JJ
,/,
2003/CD
)/)
./.
====================
Visscherand/CC
Le/NNP
Hellard/JJ
(/(
2003/CD
)/)
modify/VBP
the/DT
standard/JJ
chi-square/NN
test/NN
by/IN
incorporating/VBG
the/DT
variation/NN
inflation/NN
factor/NN
to/TO
control/VB
the/DT
type/NN
I/CD
error/NN
rate/NN
in/IN
the/DT
presence/NN
of/IN
experimental/JJ
variation/NN
./.
====================
As/IN
an/DT
alternative/JJ
approach/NN
for/IN
the/DT
analysis/NN
of/IN
pooled/JJ
data/NNS
,/,
Visscher/NNP
and/CC
Le/NNP
Hellard/JJ
(/(
2003/CD
)/)
suggest/VBP
an/DT
over­/JJ
dispersed/JJ
model/NN
,/,
which/WDT
is/VBZ
widely/RB
used/VBN
for/IN
the/DT
analysis/NN
of/IN
clustered/VBN
binary/NN
data/NNS
in/IN
statistical/JJ
literatures/NNS
(/(
Ahn/NN
etal./FW
,/,
2003/CD
;/:
Jung/NN
et/FW
al./FW
,/,
2001/CD
;/:
Kang/NNP
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
The/DT
parameters/NNS
from/IN
the/DT
over-dispersed/VBN
model/NN
can/MD
be/VB
estimated/VBN
from/IN
a/DT
nested/JJ
design/NN
of/IN
population/NN
samples/NNS
and/CC
replicated/VBD
pools/NNS
within/IN
samples/NNS
./.
====================
Kang/NN
etal/JJ
./.
====================
(/(
2004/CD
)/)
investigate/VBP
the/DT
allelic/JJ
chi-square/NN
test/NN
used/VBN
in/IN
genetic/JJ
association/NN
studies/NNS
in/IN
terms/NNS
of/IN
empirical/JJ
type/NN
I/CD
error/NN
rates/NNS
and/CC
empirical/JJ
powers/NNS
./.
====================
If/IN
the/DT
large/JJ
allele-frequency/NN
differences/NNS
are/VBP
observed/VBN
in/IN
the/DT
pools/NNS
of/IN
cases/NNS
and/CC
controls/VBZ
,/,
genotyping/VBG
is/VBZ
performed/VBN
individually/RB
./.
====================
One/CD
of/IN
the/DT
important/JJ
issues/NNS
in/IN
DNA/NN
pooling/NN
study/NN
is/VBZ
the/DT
selection/NN
of/IN
markers/NNS
to/TO
be/VB
genotyped/VBN
individually/RB
./.
====================
Development/NN
of/IN
statistical/JJ
methods/NNS
is/VBZ
needed/VBN
to/TO
determine/VB
methods/NNS
for/IN
selecting/VBG
markers/NNS
to/TO
proceed/VB
to/TO
the/DT
second/JJ
stage/NN
./.
====================
Konig/NN
and/CC
Ziegler/NN
(/(
2004/CD
)/)
propose/VBP
decision-theoretic/JJ
models/NNS
to/TO
determine/VB
individual/JJ
genotyping/VBG
based/VBN
on/IN
the/DT
results/NNS
from/IN
pooled/JJ
DNA/NN
./.
====================
Bonferroni/DT
correction/NN
,/,
false/VBP
discovery/NN
rate/NN
(/(
FDR/NN
)/)
or/CC
related/JJ
concepts/NNS
can/MD
be/VB
also/RB
used/VBN
for/IN
the/DT
selection/NN
of/IN
markers/NNS
to/TO
move/VB
to/TO
the/DT
second/JJ
stage/NN
./.
====================
In/IN
the/DT
second/JJ
stage/NN
,/,
genotyping/VBG
is/VBZ
performed/VBN
individually/RB
and/CC
markers/NNS
are/VBP
analyzed/VBN
conventionally/RB
./.
====================
A/DT
more/RBR
comprehensive/JJ
control/NN
of/IN
confounding/VBG
factors/NNS
can/MD
be/VB
done/VBN
at/IN
the/DT
second/JJ
stage/NN
./.
====================
The/DT
second/JJ
stage/NN
can/MD
enable/VB
the/DT
study/NN
of/IN
gene-gene/NN
interactions/NNS
and/CC
gene-environment/JJ
interactions/NNS
./.
====================
The/DT
importance/NN
of/IN
correcting/VBG
for/IN
multiple/JJ
comparisons/NNS
in/IN
genomic/JJ
screens/NNS
is/VBZ
well/RB
known/VBN
(/(
Lander/NN
and/CC
Kruglyak/JJ
,/,
1995/CD
)/)
./.
====================
Benjamini/NNS
and/CC
Hochberg/NN
(/(
1995/CD
)/)
introduce/VBP
the/DT
false/NN
discovery/NN
rate/NN
(/(
FDR/NN
)/)
for/IN
multiple/JJ
testing/VBG
situations/NNS
./.
====================
Sabatti/NN
et/FW
al/JJ
./.
====================
(/(
2003/CD
)/)
show/VBP
that/IN
the/DT
simple/JJ
step-down/JJ
procedure/NN
introduced/VBN
by/IN
Benjamini/NN
and/CC
Hochberg/NN
(/(
1995/CD
)/)
controls/VBZ
the/DT
FDR/NN
for/IN
the/DT
dependent/JJ
tests/NNS
on/IN
which/WDT
association/NN
genome/NN
screens/NNS
are/VBP
based/VBN
through/IN
simulation/JJ
./.
====================
Even/RB
though/IN
complex/NN
diseases/NNS
are/VBP
generally/RB
caused/VBD
by/IN
multiple/JJ
genetic/JJ
variations/NNS
,/,
most/JJS
available/JJ
association/NN
methods/NNS
are/VBP
based/VBN
on/IN
the/DT
assumption/NN
that/DT
a/DT
single/JJ
genetic/JJ
variation/NN
is/VBZ
primarily/RB
responsible/JJ
for/IN
the/DT
disease/NN
under/IN
study/NN
./.
====================
Only/RB
a/DT
few/JJ
approaches/NNS
consider/VBP
interactions/NNS
of/IN
multiple/JJ
genes/NNS
and/CC
environmental/JJ
factors/NNS
in/IN
identifying/VBG
====================
susceptibility/NN
loci/NNS
for/IN
complex/NN
disease/NN
(/(
Hoh/NN
et/FW
al./FW
,/,
2001/CD
;/:
Ritchie/NNP
etal./FW
,/,
2001/CD
;/:
Nelson/NNP
etal./FW
,/,
2001/CD
;/:
Kim/NN
etal./FW
,/,
2003/CD
;/:
Hao/NNP
etal./FW
,/,
2004/CD
)/)
./.
====================
Hoh/NN
etal/JJ
./.
====================
(/(
2001/CD
)/)
develop/VBP
a/DT
novel/JJ
test/NN
procedure/NN
,/,
called/VBN
a/DT
set/NN
association/NN
approach/NN
,/,
to/TO
identify/VB
genetic/JJ
variation/NN
responsible/JJ
for/IN
complex/NN
diseases/NNS
when/WRB
multiple/JJ
genes/NNS
are/VBP
involved/VBN
./.
====================
This/DT
approach/NN
is/VBZ
appropriate/JJ
for/IN
many/JJ
study/NN
designs/VBZ
,/,
such/JJ
as/IN
case-control/JJ
,/,
trio/NN
and/CC
extended/VBD
families/NNS
./.
====================
The/DT
method/NN
uses/VBZ
a/DT
score/NN
statistic/JJ
that/DT
is/VBZ
weighted/VBN
by/IN
the/DT
allele/NN
contribution/NN
to/TO
a/DT
Hardy-Weinberg/JJ
equilibrium/NN
measurement/NN
./.
====================
All/DT
alleles/NNS
are/VBP
jointly/RB
estimated/VBN
and/CC
the/DT
minimal/JJ
p-value/JJ
identifies/VBZ
the/DT
combination/NN
of/IN
alleles/NNS
,/,
across/IN
genes/NNS
that/WDT
appear/VBP
to/TO
act/VB
in/IN
concert/NN
to/TO
alter/VB
the/DT
risk/NN
of/IN
disease/NN
./.
====================
They/PRP
applied/VBD
the/DT
set/NN
association/NN
approach/NN
to/TO
a/DT
real/JJ
restenosis/NN
data/NNS
set/VBP
and/CC
could/MD
identify/VB
several/JJ
SNPs/NNS
of/IN
interest/NN
that/IN
were/VBD
in/IN
linkage/NN
disequilibrium/NN
with/IN
susceptibility/NN
locus/NN
for/IN
restenosis/NN
,/,
and/CC
the/DT
re-blockage/NN
of/IN
the/DT
coronary/JJ
after/IN
treatment/NN
./.
====================
Zee/NN
etal/JJ
./.
====================
(/(
2002/CD
)/)
use/VBP
this/DT
approach/NN
to/TO
define/VB
a/DT
panel/NN
of/IN
contributory/JJ
genes/NNS
in/IN
instant/JJ
restenosis/NN
./.
====================
Hoh/NN
etal/JJ
./.
====================
(/(
2001/CD
)/)
did/VBD
not/RB
evaluate/VB
the/DT
empirical/JJ
the/DT
type/NN
I/CD
errors/NNS
and/CC
empirical/JJ
powers/NNS
of/IN
the/DT
set/NN
association/NN
approach/NN
./.
====================
Hao/RB
et/FW
al/JJ
./.
====================
(/(
2004/CD
)/)
systematically/RB
evaluate/VBP
the/DT
performances/NNS
of/IN
multiple/JJ
SNP/NN
association/NN
test/NN
in/IN
terms/NNS
of/IN
power/JJR
and/CC
accuracy/NN
in/IN
capturing/VBG
the/DT
real/JJ
disease/NN
SNPs/NNS
./.
====================
Hao/RB
etal/JJ
./.
====================
(/(
2004/CD
)/)
show/VBP
that/IN
the/DT
inclusion/NN
of/IN
Hardy-Weinberg/JJ
Disequilibrium/NN
(/(
HWD/NN
)/)
reduces/VBZ
the/DT
power/NN
through/IN
simulation/JJ
./.
====================
They/PRP
demonstrate/VBP
that/IN
the/DT
test/NN
procedure/NN
could/MD
capture/VB
the/DT
SNPs/NNS
associated/VBN
with/IN
disease/NN
fairly/RB
successfully/RB
./.
====================
Romero/NN
et/FW
al/JJ
./.
====================
(/(
2002/CD
)/)
propose/VBP
guidelines/NNS
for/IN
the/DT
evaluation/NN
of/IN
reports/NNS
of/IN
genetic/JJ
association/NN
studies/NNS
including/VBG
selection/NN
of/IN
SNPs/NNS
,/,
study/NN
design/NN
,/,
assay/NN
characteristics/NNS
,/,
sample/JJ
size/NN
determination/NN
,/,
multiple/JJ
tests/NNS
and/CC
statistical/JJ
analysis/NN
./.
====================
Proposed/VBN
guidelines/NNS
for/IN
the/DT
reporting/VBG
of/IN
genetic/JJ
association/NN
studies/NNS
facilitate/VBP
the/DT
peer/NN
review/NN
process/NN
,/,
publication/NN
,/,
and/CC
availability/NN
of/IN
the/DT
data/NNS
for/IN
future/JJ
studies/NNS
and/CC
systematic/JJ
reviews/VBZ
./.
====================
DNA/NN
pooling/NN
technique/NN
is/VBZ
ideal/JJ
for/IN
screening/NN
a/DT
large/JJ
number/NN
of/IN
markers/NNS
for/IN
associations/NNS
although/IN
positive/JJ
results/NNS
will/MD
require/VB
confirmation/NN
through/IN
individual/JJ
genotyping/VBG
./.
====================
Considerable/JJ
savings/NNS
can/MD
be/VB
achieved/VBN
concerning/VBG
DNA/NN
,/,
cost/JJ
and/CC
labor/NN
through/IN
the/DT
use/NN
of/IN
DNA/NN
pooling/NN
./.
====================
All/DT
markers/NNS
identified/VBD
in/IN
the/DT
initial/JJ
discovery/NN
process/NN
are/VBP
subjected/VBN
to/TO
a/DT
follow-up/JJ
program/NN
./.
====================
Additional/JJ
work/NN
is/VBZ
necessary/JJ
to/TO
eliminate/VB
false-positive/JJ
associations/NNS
that/IN
are/VBP
likely/JJ
due/JJ
to/TO
sampling/JJ
errors/NNS
and/CC
potential/JJ
population/NN
substructures/NNS
./.
====================
The/DT
most/JJS
powerful/JJ
method/NN
is/VBZ
the/DT
application/NN
of/IN
observations/NNS
in/IN
one/CD
or/CC
more/RBR
independent/JJ
samples/NNS
./.
====================
That/DT
is/VBZ
,/,
replicate/VBP
studies/NNS
using/VBG
pooled/JJ
DNA/NN
from/IN
two/CD
or/CC
more/RBR
studies/NNS
are/VBP
expected/VBN
to/TO
====================
play/VBP
an/DT
efficient/JJ
role/NN
in/IN
eliminating/VBG
false/VBP
positive/JJ
findings/NNS
,/,
and/CC
for/IN
the/DT
efficient/JJ
identification/NN
of/IN
meaningful/JJ
association/NN
./.
====================
Considerable/JJ
cost/JJS
reduction/NN
can/MD
be/VB
achieved/VBN
through/IN
the/DT
use/NN
of/IN
DNA/NN
pooling/NN
,/,
whereby/RB
DNA/NN
samples/NNS
from/IN
multiple/JJ
individuals/NNS
are/VBP
pooled/JJ
before/IN
genotyping/VBG
./.
====================
It/PRP
is/VBZ
suggested/VBN
that/IN
DNA/NN
pooling/NN
should/MD
be/VB
considered/VBN
especially/RB
in/IN
the/DT
initial/JJ
stages/NNS
of/IN
a/DT
major/JJ
program/NN
aimed/VBD
at/IN
genome-wide/NN
association/NN
studies/NNS
since/IN
large-scale/JJ
association/NN
studies/NNS
can/MD
be/VB
accelerated/VBN
with/IN
the/DT
use/NN
of/IN
DNA/NN
pooling/NN
./.
====================
